|
Volumn 7, Issue 8, 2014, Pages 843-845
|
OCT imaging for the management of pulmonary hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN NATRIURETIC PEPTIDE;
SPIRONOLACTONE;
URIC ACID;
PRESCRIPTION DRUG;
ANTIHYPERTENSIVE THERAPY;
ARTERIAL WALL THICKNESS;
ARTERY DIAMETER;
CONNECTIVE TISSUE DISEASE;
CONTROLLED STUDY;
DISEASE COURSE;
FOLLOW UP;
HEART CATHETERIZATION;
HEART INDEX;
HOSPITAL PATIENT;
HUMAN;
IMAGING SYSTEM;
LETTER;
MAJOR CLINICAL STUDY;
OPTICAL COHERENCE TOMOGRAPHY;
OPTICAL COHERENCE TOMOGRAPHY DEVICE;
PREDICTIVE VALUE;
PREVALENCE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PULMONARY ARTERY;
PULMONARY HYPERTENSION;
URIC ACID BLOOD LEVEL;
ARTERIAL PRESSURE;
CASE CONTROL STUDY;
COMPUTER ASSISTED DIAGNOSIS;
HYPERTENSION, PULMONARY;
PATHOLOGY;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
VASCULAR REMODELING;
DIURETIC THERAPY;
IMAGING SOFTWARE;
LUNG VASCULAR RESISTANCE;
PRESCRIPTION;
PROGNOSIS;
PULMONARY ARTERY REMODELING;
PULMONARY VASCULAR DISEASE;
ARTERIAL PRESSURE;
CARDIAC CATHETERIZATION;
CASE-CONTROL STUDIES;
HUMANS;
HYPERTENSION, PULMONARY;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
PREDICTIVE VALUE OF TESTS;
PROSPECTIVE STUDIES;
PULMONARY ARTERY;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR REMODELING;
|
EID: 84905982278
PISSN: 1936878X
EISSN: 18767591
Source Type: Journal
DOI: 10.1016/j.jcmg.2014.01.020 Document Type: Letter |
Times cited : (25)
|
References (2)
|